Ironwood Pharmaceuticals is trading 5.03% higher at $3.78 as of 10:39 a.m. ET on October 15, 2026; broader biotech strength may be supporting the move. - No company-specific news explaining the gain was found; XBI is up 2.20%. - An October 15 report describes a significant FDA setback for apraglutide and says shares fell after disclosure; that adverse news does not explain today’s rise. - No volume information is available in the provided price context.